Obicetrapib sodium
Based on 1 publication(s) in Google Scholar
Obicetrapib (TA-8995; DEZ-001) sodium is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib sodium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib sodium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 866399-88-4
- 화학식: C32H30F9N4NaO5
- 분자량:744.58
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
|
apoB |
CETP |
Chemical Information
-
CAS No. 866399-88-4
-
분자량 744.58
-
화학식 C32H30F9N4NaO5
-
SMILES
FC(F)(F)C1=CC(C(F)(F)F)=CC(CN(C2=NC=C(OCCCC(O[Na])=O)C=N2)[C@@H]3C4=CC(C(F)(F)F)=CC=C4N([C@@H](C3)CC)C(OCC)=O)=C1
-
Synonyms
TA-8995 sodium; DEZ-001 sodium; AMG-899 sodium
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)